Molecular Cancer Therapeutics
E7309
Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Molecular Cancer Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T77836 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Molecular Cancer Therapeutics Context triple: [American Association for Cancer Research, publishes, Molecular Cancer Therapeutics]
-
A.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
B.
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed scientific journal focusing on research into the causes, prevention, and early detection of cancer through epidemiologic and biomarker studies.
-
C.
Cancer Research
Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
-
D.
American Association for Cancer Research
The American Association for Cancer Research is a leading professional organization dedicated to advancing cancer research, prevention, diagnosis, and treatment through scientific collaboration and dissemination of findings.
-
E.
Molecular Biology of the Cell
Molecular Biology of the Cell is a leading peer-reviewed scientific journal that publishes research and reviews in cell biology and related molecular life sciences.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Molecular Cancer Therapeutics Target entity description: Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
-
A.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
B.
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed scientific journal focusing on research into the causes, prevention, and early detection of cancer through epidemiologic and biomarker studies.
-
C.
Cancer Research
Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
-
D.
American Association for Cancer Research
The American Association for Cancer Research is a leading professional organization dedicated to advancing cancer research, prevention, diagnosis, and treatment through scientific collaboration and dissemination of findings.
-
E.
Molecular Biology of the Cell
Molecular Biology of the Cell is a leading peer-reviewed scientific journal that publishes research and reviews in cell biology and related molecular life sciences.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
academic journal
ⓘ
peer-reviewed journal ⓘ scientific journal ⓘ |
| academicDiscipline |
cancer research
ⓘ
drug development ⓘ oncology ⓘ pharmacology ⓘ |
| field |
biomedical sciences
ⓘ
medical sciences ⓘ |
| focusesOn |
biologic cancer drugs
ⓘ
biomarkers for cancer therapy ⓘ clinical evaluation of cancer therapeutics ⓘ combination cancer therapies ⓘ development of cancer therapeutics ⓘ discovery of cancer therapeutics ⓘ immuno-oncology agents ⓘ mechanisms of drug resistance in cancer ⓘ molecularly targeted agents ⓘ preclinical cancer models ⓘ signal transduction inhibitors ⓘ small-molecule cancer drugs ⓘ targeted cancer therapies ⓘ translational cancer research ⓘ |
| hasFormat |
online
ⓘ
print ⓘ |
| hasReviewProcess | peer review ⓘ |
| hasScope | discovery to clinical evaluation of cancer therapeutics ⓘ |
| language | English ⓘ |
| peerReviewed | true ⓘ |
| publishes |
early-phase clinical trials
ⓘ
original research articles ⓘ preclinical studies ⓘ reviews ⓘ short communications ⓘ |
| subjectArea |
biomarker-driven therapy
ⓘ
clinical translation of cancer therapies ⓘ drug resistance in cancer ⓘ molecular mechanisms of anticancer agents ⓘ novel cancer therapeutics ⓘ pharmacodynamics of cancer drugs ⓘ pharmacokinetics of cancer drugs ⓘ precision oncology ⓘ preclinical drug development ⓘ |
| targetAudience |
cancer researchers
ⓘ
clinical oncologists ⓘ pharmaceutical scientists ⓘ translational researchers ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Molecular Cancer Therapeutics Description of subject: Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.